Glenmark Pharma's innovation arm, IGI, received FDA fast track designation for its myeloma therapy ISB 2001, targeting heavily pre-treated RRMM patients. The tri-specific antibody showed high response rates and a favorable safety profile in early trials. Complete results will be presented at ASCO 2025. The stock rose 2.2% on Monday, with analysts maintaining a 'Buy' rating.
DCM Shriram's shares surged by 10.5% following a robust Q4 FY25 performance, with net profit soaring 51.9% to Rs 178.9 crore. Revenue climbed 19.9% to Rs 2,876.7 crore, driven by strong segment results and improved EBITDA margins of 14.1%. The board has proposed a final dividend of Rs 3.40 per share.
From the tactical success of the Elever FactorShields Fund, which delivered 20% returns in FY25, to sharp views on the US-led macro shifts and sector rotation strategies, Aggarwal outlines how investors can align portfolios for stability and long-term alpha. Edited Excerpts
In an exclusive interview with ETMarkets, Lakhotia shares his ideal portfolio mix for this age group, highlighting a 50% allocation to equities, 20% to gold, 10% to REITs or international funds, and 20% to debt instruments.
In the Nifty200 pack, nine stocks' close prices crossed above their 200 DMA (Daily Moving Averages) on May 05, according to stockedge.com's technical scan data. The 200-day DMA is used as a key indicator by traders for determining the overall trend in a particular stock. As long as the stock is priced above the 200-day SMA on the daily time frame, it is generally considered to be an overall uptrend. Take a look:
The fourth quarter earnings season is gaining traction, with several companies, including Bank of Baroda, Paytm, BSE, and HPCL, set to announce their results on Tuesday. Paytm's Q4FY25 earnings are keenly anticipated, with some brokerages projecting a profit, while others foresee a reduced loss.
Ather Energy, a leading Indian EV brand, is set to debut on the NSE and BSE after a modest IPO subscription. Despite strong brand equity and tech credentials, the company faces challenges with profitability, reporting a significant net loss for FY24. Its future stock performance depends on scaling profitably and defending market share in a competitive EV market.
Hollywood is in turmoil following President Trump's announcement of a potential 100% tariff on foreign films, a move criticized by industry insiders as impractical and harmful. The proposal has sparked uncertainty, causing stock prices to fall and raising questions about its enforceability.
